Changge Fang

Title: Changge Fang: Innovator in Cancer Research

Introduction

Changge Fang is a prominent inventor based in Alexandria, VA, who has made significant contributions to the field of cancer research. His work focuses on innovative methods for monitoring angiogenesis and metastasis, which are critical processes in cancer progression. With a patent portfolio that includes groundbreaking techniques, Fang is at the forefront of developing personalized therapeutics for cancer treatment.

Latest Patents

Changge Fang holds a patent titled "Methods of monitoring angiogenesis and metastasis in three-dimensional co-cultures." This patent relates to the use of fluorescent cell lines to monitor cellular activity, particularly angiogenesis. The innovative approach involves utilizing these cell lines in a three-dimensional cell culture to assess the angiogenic and metastatic potential of tumor cells. This research is pivotal in selecting personalized therapeutics for cancer treatment, enhancing the effectiveness of therapies tailored to individual patients.

Career Highlights

Fang is affiliated with the National Institutes of Health, a component of the US Department of Health & Human Services. His role at this esteemed institution allows him to collaborate with leading experts in the field and contribute to groundbreaking research that has the potential to transform cancer treatment.

Collaborations

Some of Changge Fang's notable coworkers include Enrique Zudaire and Frank Cuttitta. Their collaborative efforts in research and development further enhance the impact of Fang's work in the scientific community.

Conclusion

Changge Fang's innovative research and patented methods are making significant strides in the fight against cancer. His contributions to monitoring angiogenesis and metastasis are paving the way for more effective and personalized cancer therapies.